Amissa Health
.png&w=3840&q=75)
Overview
Amissa Health is a digital health company based in Charlotte, North Carolina, specializing in the use of wearable technology and data analytics to improve outcomes for conditions like Alzheimer's disease and menopause. The company, founded by Colby Ford and Jon A. Corkey in 2017, focuses on the prediction, early identification, and prevention of dementias through real-world digital biomarkers. Amissa has raised over $3.7 million in funding to date, including significant grants from the National Institutes of Health.
Recent Developments
- September 2024: Amissa Health secured a $2.52 million grant from the National Institutes of Health to expand its digital health initiatives, focusing on remote patient monitoring using wearable technology.
- August 2024: The company received a $505,000 grant from the National Institute on Aging to support research on Alzheimer's disease prevention.
- January 2024 - June 2024: A pilot study was conducted utilizing Apple Watches to monitor health and behaviors of individuals with cognitive impairments, successfully collecting extensive biometric data.
- October 2023: Amissa Health raised additional funding of $50,000 from TFX Capital to enhance its technological capabilities.
- 2023 - 2024: The company has been actively involved in collaborative research with institutions like Washington University in St. Louis, focusing on integrating wearable sensor and driving data to predict cognitive decline.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | April 24, 2017 |
| Headquarters | Charlotte, North Carolina |
| Founders | Colby Ford, Jon A. Corkey |
| Revenue | <$5 Million |
| Key Investors | NIH, National Institute on Aging |
| Industry | Healthcare, Digital Health |
| Number of Employees | 2-10 |
Early History
Amissa Health was established in 2017 with the vision of leveraging wearable technology to gather and analyze health data. The company quickly engaged in developing a platform that could collect real-time biomedical information to create predictive models for health conditions like Alzheimer’s. Early efforts were supported by various grants and the company's participation in innovation programs, allowing it to establish a foothold in digital health research.
Company Profile and Achievements
Amissa Health has pioneered the convergence of AI-driven analytics and wearable technology to address age-related health issues.
- Developed a platform, AmissaWear, that integrates with smartwatches to monitor health metrics like heart rate, sleep patterns, and physical activity.
- Participated in NIH-funded studies that classify preclinical Alzheimer’s disease status in older adults by analyzing data from wearable sensors.
- Established collaborations with leading research institutions to bolster its research and development initiatives.
- Significantly increased its funding through federal grants, enabling strategic expansion and technological upgrades.
- Its products and solutions include AmissaWear, AmissaOrbis, and AmissaCare, designed to enhance remote health monitoring capabilities.
Current Operations and Market Position
Amissa Health is currently concentrated on expanding its reach in the digital health sector by enhancing its data collection methodologies and integrating diverse healthcare datasets. The company is recognized for its innovative approaches to disease prevention through digital health monitoring and is gaining traction for identifying new digital biomarkers. It maintains a competitive advantage through specialized partnerships and ongoing advancements in sensory technology and AI analytics.
Conclusion
Amissa Health stands at the forefront of healthcare innovation, utilizing cutting-edge wearable technologies and data analytics to drive advancements in disease prevention and monitoring. With a steady stream of funding and strategic partnerships with diverse educational and research institutions, Amissa Health is poised for substantial growth. As the digital health landscape evolves, Amissa's commitment to deploying AI to improve health outcomes underscores its potential to impact the industry significantly.